Bellevue F.(L)-B.Obesity Sol.B EUR/ LU0415392249 /
| NAV2024-04-18 | Chg.-2.6000 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 615.4700EUR | -0.42% | reinvestment | Equity Worldwide | Waystone M.Co.(Lux) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2009 | - | - | - | - | -2.57 | 6.12 | 6.42 | -1.06 | 3.16 | -11.73 | 4.92 | 5.03 | - |
| 2010 | 4.64 | 4.78 | 5.80 | 0.08 | -5.05 | -3.26 | -3.14 | 0.42 | 4.28 | 4.50 | 1.74 | 4.27 | +19.88% |
| 2011 | -5.00 | -0.58 | -1.77 | 3.43 | 3.21 | -1.63 | -1.22 | -13.48 | -0.20 | 1.92 | 4.02 | 6.76 | -5.94% |
| 2012 | 12.44 | -0.50 | 3.77 | 0.96 | 6.42 | 1.08 | 6.96 | -0.39 | 3.53 | -9.25 | 4.57 | -1.92 | +29.46% |
| 2013 | 4.41 | 5.53 | 9.71 | 6.48 | 4.70 | -4.20 | 12.28 | -2.09 | 6.27 | -3.63 | 8.04 | -0.23 | +56.68% |
| 2014 | 12.36 | 4.08 | -10.71 | -4.63 | 4.48 | 8.14 | 1.15 | 13.08 | 3.01 | 11.02 | 3.10 | 2.31 | +55.24% |
| 2015 | 15.70 | 6.35 | 4.96 | -7.88 | 12.24 | -2.01 | 2.87 | -12.82 | -12.03 | 10.61 | 7.05 | -1.90 | +19.90% |
| 2016 | -22.80 | -5.60 | -0.37 | 3.47 | 6.31 | -9.21 | 12.44 | -2.44 | 1.99 | -11.88 | 12.34 | -3.40 | -22.44% |
| 2017 | 4.88 | 9.03 | -1.17 | -0.11 | -6.90 | 5.94 | -0.60 | 3.74 | -0.40 | -4.51 | -1.17 | 0.22 | +8.16% |
| 2018 | 3.89 | -3.58 | -1.45 | -3.67 | 7.62 | 0.05 | 5.87 | 5.57 | -1.15 | -14.31 | 3.97 | -11.59 | -10.90% |
| 2019 | 12.60 | 5.04 | 2.34 | -6.54 | -3.79 | 6.84 | 0.70 | -2.10 | -2.56 | 4.10 | 12.62 | -0.56 | +30.22% |
| 2020 | -4.31 | -1.24 | -7.93 | 14.96 | 8.30 | 2.75 | -6.28 | -0.07 | 1.47 | -3.48 | 8.90 | 1.51 | +12.85% |
| 2021 | 5.15 | -2.35 | -2.48 | 1.64 | -0.55 | 8.16 | 3.03 | 2.48 | -4.04 | -0.09 | -1.32 | -0.75 | +8.52% |
| 2022 | -10.97 | -3.28 | 6.11 | -3.22 | -4.13 | 4.31 | 6.27 | -1.04 | 0.92 | 5.75 | 1.93 | -7.44 | -6.36% |
| 2023 | 0.33 | -4.49 | -1.33 | 0.33 | 1.40 | -2.86 | -0.75 | 0.40 | -1.66 | -6.79 | 0.37 | 0.92 | -13.55% |
| 2024 | 4.18 | 3.68 | 2.68 | -4.51 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 9.78% | 13.05% | 13.13% | 19.50% | 22.75% |
| Sharpe ratio | 1.81 | -0.16 | -0.68 | -0.32 | 0.01 |
| Best month | +4.18% | +4.18% | +4.18% | +8.16% | +14.96% |
| Worst month | -4.51% | -6.79% | -6.79% | -10.97% | -10.97% |
| Maximum loss | -4.51% | -7.83% | -15.77% | -28.39% | -29.23% |
| Outperformance | +9.35% | - | +7.75% | -0.01% | -12.93% |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Bellevue F.(L)-B.Obesity Sol.I2 ... | reinvestment | 161.0600 | -4.18% | -4.49% | |
| Bellevue F.(L)-B.Obesity Sol.I U... | reinvestment | 548.0900 | -6.99% | -15.69% | |
| Bellevue F.(L)-B.Obesity Sol.I E... | reinvestment | 688.9000 | -4.31% | -4.90% | |
| Bellevue F.(L)-B.Obesity Sol.I C... | reinvestment | 440.6400 | -5.50% | -16.00% | |
| Bellevue F.(L)-B.Obesity Sol.I G... | reinvestment | 465.3900 | -7.12% | -5.24% | |
| Bellevue F.(L)-B.Obesity Sol.B U... | reinvestment | 491.4700 | -7.64% | -17.44% | |
| Bellevue F.(L)-B.Obesity Sol.B C... | reinvestment | 393.0000 | -6.16% | -17.74% | |
| Bellevue F.(L)-B.Obesity Sol.B E... | reinvestment | 615.4700 | -4.98% | -6.87% |
Performance
| YTD | +5.91% | ||
|---|---|---|---|
| 6 Months | +0.87% | ||
| 1 Year | -4.98% | ||
| 3 Years | -6.87% | ||
| 5 Years | +22.84% | ||
| Since start | +392.38% | ||
| Year | |||
| 2023 | -13.55% | ||
| 2022 | -6.36% | ||
| 2021 | +8.52% | ||
| 2020 | +12.85% | ||
| 2019 | +30.22% | ||
| 2018 | -10.90% | ||
| 2017 | +8.16% | ||
| 2016 | -22.44% | ||
| 2015 | +19.90% | ||
